Levels of BAFF in serum in primary biliary cirrhosis and autoimmune diabetes

Autoimmunity

Volumn 35, Issue 8, 2002, Pages 551-553

  MacKay, I R ^a   Groom, J ^b   MacKay, C R ^b  

^a MONASH UNIVERSITY   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Autoimmunity; BAFF; Diabetes; LADA; Primary biliary cirrhosis

Indexed keywords

B LYMPHOCYTE ACTIVATING FACTOR OF THE TUMOR NECROSIS FAMILY; CYTOKINE; INSULIN; MITOCHONDRION ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; B LYMPHOCYTE ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE COURSE; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; PRIMARY BILIARY CIRRHOSIS; PROTEIN BLOOD LEVEL; RELAPSE; SJOEGREN SYNDROME; SURVIVAL;

B-CELL ACTIVATING FACTOR; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LIVER CIRRHOSIS, BILIARY; MEMBRANE PROTEINS; SJOGREN'S SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036940946     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/0891693021000066333     Document Type: Article

References (11)

1. Groom, J., Kalled, S.L., Cutler, A.H., Olson, C., Woodcock, S.A., Schneider, P., Tschopp, J., Cachero, T.G., Batten, M., Wheway, J., Mauri, D., Cavill, D., Gordon, T.P., Mackay, C.R. and Mackay, F. (2002) "Association of BAFF/BLys overexpression and altered B cell differentiation with Sjögren's syndrome", J. Clin. Investig. 109, 59-68.
2. Mackay, F. and Mackay, C.R. (2002) "The role of BAFF in B-cell maturation, T-cell activation and autoimmunity", Trends Immunol. 23, 113-115.
3. Shi, X., Xie, C., Kreska, D., Richardson, J.A. and Mohan, C. (2002) "Genetic dissection of SLE: SLE1 and FAS impact alternate pathways leading to lymphoproliferative autoimmunity", J. Exp. Med. 196, 281-292.
4. Strasser, A., Whittingham, S., Vaux, D., Bath, M.L., Adams, J.M., Cory, S., Adams, J. and Harris, A.W. (1991) "Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease", Proc. Natl. Acad. Sci. USA 88, 8661-8665.
5. Chambers, C.A., Kang, J., Wu, Y., Heid, W., Roulet, D.H. and Allison, J.P. (2002) "The lymphoproliferative defect in CTLA-4-deficient mice is ameliorated by an inhibitory NK cell receptor", Blood 99, 4509-4516.
6. Cheema, G.S., Roschke, V., Hilbert, D.M. and Stohl, W. (2001) "Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases", Arthritis Rheum. 44, 1313-1319.
7. Zhang, J., Roschke, V., Baker, K.P., Wang, Z., Alarcón, G.S., Fessler, B.J., Bastian, H., Kimmberley, R.P. and Zhou, T. (2001) "A role for B lymphocyte stimulator in systemic lupus erythematosus", J. Immunol. 166, 6-10.
8. Mackay, I.R., Whittingham, S.F., Fida, S., Myers, M., Ikuno, N., Gershwin, M.E. and Rowley, M.J. (2000) "The peculiar autoimmunity of primary biliary cirrhosis", Immunol. Rev. 174, 210-225.
9. Chen, Q-Y., Rowley, M.J., Byrne, G.C., Jones, T.W., Tuomi, T., Knowles, W.J., Zimmet, P.Z. and Mackay, I.R. (1983) "Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives", Ped. Res. 34, 785-790.
10. Crapper, R.M., Blathal, P.S. and Frazer, I.H. (1986) "Acute autoimmune hepatitis", Digestion 34, 216-225.
11. Mackay, I.R. and Rose, N.R. (2001) "Autoimmunity and lymphoma: Tribulations of B cells", Nat. Immunol. 2, 793-795.